These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 416168)

  • 21. The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells.
    Boyd AW; Pike BL
    Eur J Immunol; 1982 Mar; 12(3):184-8. PubMed ID: 6807696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR; Subbarao B
    J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human b-cell differentiation. I. Analysis of immunoglobulin heavy chain switching using monoclonal anti-immunoglobulin M, G, and A antibodies and pokeweed mitogen-induced plasma cell differentiation.
    Kuritani T; Cooper MD
    J Exp Med; 1982 Mar; 155(3):839-51. PubMed ID: 6801181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
    Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
    J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.
    Chen-Bettecken U; Wecker E; Schimpl A
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7384-8. PubMed ID: 3933005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic treatment with rabbit anti-mouse mu-chain antibody alters the characteristic immunoglobulin heavy-chain restriction of murine suppressor T-cell factors.
    Sy MS; Lowy A; HayGlass K; Janeway CA; Gurish M; Greene MI; Benacerraf B
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3846-50. PubMed ID: 6233614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitogenic effect on human lymphocytes of insolubilized anti-immunoglobulins. I. Specificity of the stimulating agent.
    Henriksen A; Godal T; Landaas TO
    J Immunol; 1980 Feb; 124(2):921-5. PubMed ID: 6766166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin secretion by human splenic lymphocytes in vitro: the effects of antibodies to IgM and IgD.
    Finkelman FD; Lipsky PE
    J Immunol; 1978 May; 120(5):1465-72. PubMed ID: 96179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
    Phillips NE; Gravel KA; Tumas K; Parker DC
    J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
    Hamano T; Asofsky R
    J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and biological function of human IgD. IX. Anti-IgD activation of human lymphocytes.
    Kermani-Arab V; Leslie GA; Burger DR
    Int Arch Allergy Appl Immunol; 1977; 54(1):1-8. PubMed ID: 405331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the variable heavy chain (VH) region of membrane-bound Ig on human chronic leukemic lymphocytes.
    Forre O; Froland SS; Natvig JB; Michaelsen TE; Johnson PM; Ly B; Laake K
    J Immunol; 1977 May; 118(5):1513-6. PubMed ID: 404355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of lipopolysaccharide content on the apparent B cell stimulating activity of anti-mu preparations.
    Wilder JA; Cowdery JS; Ashman RF
    J Immunol Methods; 1988 May; 110(1):63-8. PubMed ID: 3259611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
    Udhayakumar V; Kumar L; Subbarao B
    J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of B lymphocytes responsive to anti-immunoglobulin.
    Defranco AL; Raveche ES; Asofsky R; Paul WE
    J Exp Med; 1982 May; 155(5):1523-36. PubMed ID: 6802927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
    Schliephake DE; Schimpl A
    Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The abnormal function of T cells in chronically anti-mu-treated mice with no mature B lymphocytes.
    Kim KJ; Rollwagen F; Asofsky R; Lefkovits I
    Eur J Immunol; 1984 May; 14(5):476-82. PubMed ID: 6233161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete humoral immunosuppression of mice by rabbit anti-mu antibodies passing the murine placenta.
    Manning DD
    J Immunol; 1977 Mar; 118(3):1109-12. PubMed ID: 403234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F(ab')2 reagents are not required if goat, rather than rabbit, antibodies are used to detect human surface immunoglobulin.
    Alexander EL; Sanders SK
    J Immunol; 1977 Sep; 119(3):1084-8. PubMed ID: 330746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.